Anti-inflammatory Effects of GTS-21 After LPS

NCT00783068 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Endotoxemia
Sepsis
Vagal Activity

Interventions

DRUG: GTS-21, [3-(2,4-dimethoxybenzylidene)-anabaseine dihydrochloride]
DRUG: Placebo
DRUG: Lipopolysaccharide E. Coli 113:H 10:K negative

Sponsor

Radboud University Medical Center

Collaborators

[object Object]